ClinicalTrials.gg
Not yet recruitingNCT07837089Updated Sep 23, 2026

Increasing Engagement With Digital Behavioral Health

An interventional study of Live Virtual Coaching in Cancer Survivorship, sponsored by Hackensack Meridian Health. Not yet recruiting at 1 site in United States. Open to participants aged 18 Years to 39 Years. Per ClinicalTrials.gov, last updated 2026-09-23.

Sponsored by Hackensack Meridian Health · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
13
Allocation
Not applicable
Ages
18 Years to 39 Years
Sex
All
01

Study summary

This is a phased mixed-methods behavioral intervention study that will develop and test Mindful Peer Coach, a peer-supported mindfulness program for adolescent and young adult (AYA) cancer survivors. Phase 1 is a formative qualitative study designed to identify survivor-reported needs and preferences for increasing engagement with a mindfulness meditation app. Phase 2 is a pilot intervention study that will examine the feasibility, acceptability, and preliminary engagement outcomes of the Mindful Peer Coach program using participant surveys, app-use data, peer-coach training, coaching sessions, weekly text-message check-ins, and exit interviews with survivors and coaches.

02

Conditions studied

  • Cancer Survivorship

Keywords

  • Cancer survivorship
  • supporting care for cancer survivors
  • digital health intervention
  • user engagement
03

In context

Lead sponsor

Hackensack Meridian Health is the lead sponsor of 113 studies on the registry; 28 are open to participants now.

Of its 17 completed or terminated interventional studies of FDA-regulated products, 12 (71%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 39 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • at least one year from treatment completion
  • ability to speak conversational English,
  • per self-report, not being treated for posttraumatic stress disorder (PTSD), psychosis, or epilepsy/seizures.
  • have experience with mindfulness and/or be willing to attend training and supervision sessions (only for coaches)
  • at least two years from treatment completion (only for coaches) ;

Exclusion criteria

Exclusion Criteria:

  • outside age range
  • closer to treatment completion than specified above
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
13 participants (estimated)

Study arms

  • Experimental
    Mindful Peer Coaching

    Mindful Peer Coach consists of 1) live virtual and 2) text message coaching.

    Behavioral: Live Virtual Coaching

Interventions

  • BehavioralLive Virtual Coaching

    Participants will complete six structured weekly videoconference sessions designed to cultivate mindfulness practice and increase engagement with the Happier Meditation app. Each session follows a standardized framework outlined in the training manual to ensure consistency and fidelity. Between sessions, coaches will provide support and accountability via text messaging. The frequency of messages will be determined collaboratively during Session 1. Each exchange begins with a previously tested mindfulness message, followed by tailored responses to reinforce practice, address questions, and sustain engagement.

06

What researchers measure

Primary outcomes

  1. Minutes use per day (User engagement)

    Minutes use per day with the mindfulness-based mobile app obtained from the Happier Meditation dashboard.

    Time frame: Minutes used per day will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase

  2. Number of days used per week (User engagement)

    Number of days used per week with the mindfulness-based mobile app obtained from the Happier Meditation dashboard.

    Time frame: Number of days used per week will be captured daily through the app and summarized weekly across the full 3-month study period, including the 8-week intervention phase.

  3. Depression

    Depression symptoms will be assessed using the PROMIS Depression measure. PROMIS Depression is an 8-item scale with each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 8 to 40 with higher scores indicating greater severity of depression.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

  4. Anxiety

    Anxiety symptoms will be assessed using the PROMIS Anxiety measure. PROMIS Anxiety is an 7-item scale with each item on the measure is rated on a 5-point scale (1=never; 2=rarely; 3=sometimes; 4=often; and 5=always) with a range in score from 7 to 35 with higher scores indicating greater severity of anxiety.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

  5. Mindfulness

    Mindfulness will be assessed using the Mindful Attention Awareness Scale measure. Your score falls into a range of 1 to 6, calculated by taking the average of all 15 responses. Higher average scores indicate greater overall mindfulness.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

  6. Emotion Regulation

    Emotion Regulation will be assessed using the emotional experience subscale from the Emotion Regulation Questionnaire (ERQ) measure. The Emotion Regulation has 6 items on a 7-point Likert scale, with 1 indicating "strongly disagree" and 7 indicating "strongly agree" ranging from 6 to 42 (computed as the mean of the 6 items). Higher scores indicate a greater tendency to alter how you think about a situation to change its emotional impact.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

  7. Positive and Negative Emotions

    Positive and Negative Emotions will be assessed using I-PANAS-SF (International Positive and Negative Affect Schedule Short-Form). It is a 10-item psychological tool that assesses affect. It evaluates both Positive Affect and Negative Affect on two separate 5-item subscales. Each of the 10 emotions is rated on a 5-point Likert scale, resulting in score ranges of 5 to 25 for both the Positive and Negative subscales. Higher scores indicate higher levels of that specific effect.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

  8. Distress

    Distress will be assessed using the Perceived Stress Scale. The Perceived Stress Scale (PSS-10) is a 10 item scale that has a total score range from 0 to 40, with higher scores indicating higher levels of perceived stress.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

  9. Overall Wellbeing

    Overall Wellbeing will be assessed using the PROMIS Global Health scale. For the standard PROMIS Global Health (PROMIS-GH-10) assessment, the 10 items produce two distinct summary scales: Global Physical Health and Global Mental Health. Because both subscales are made up of 4 items measured on a 1-5 point scale, the raw score range for each subscale is 4 to 20. While raw scores are simply the sum of your responses, they are not used directly to interpret health status. Instead, raw scores are converted into standardized T-scores using an established lookup algorithm: A T-score of 50 represents the average health of the U.S. general population. Every 10 points away from 50 equates to one standard deviation. Higher T-scores indicate better self-reported health, regardless of whether it is the physical or mental subscale.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

  10. Sleep Disturbance

    Sleep Disturbance will be assessed using the PROMIS Sleep Disturbance scale. The raw score range for the PROMIS Sleep Disturbance Scale 4-Item Short Forms: is generally 4 to 20. Higher raw scores correspond to a greater severity of sleep disturbance. These raw scores are then converted into a standardized T-score (where the general U.S. population average is 50, with a standard deviation of 10) using PROMIS Standardized Lookup Tables.

    Time frame: Assessed at baseline, 2 weeks, 4 weeks, and 8 weeks

Secondary outcomes

  1. Exit Interview

    Qualitative feedback collected through semi-structured exit interviews; no quantifiable data will be generated. Themes will be identified and presented using descriptive statistics.

    Time frame: At the end of the 8-week intervention period

07

Study locations

1 site
  • HMH Center for Discovery and Innovation
    Nutley, New Jersey 07110, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Dec 2029, 35 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 17, 2026
First posted
Sep 23, 2026
StartEst.
Dec 15, 2026
Primary completionEst.
Dec 14, 2029
CompletionEst.
Mar 15, 2030
Last update
Sep 23, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 23, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07837089
Responsible party
Sponsor
First posted
Sep 23, 2026
Start date
Dec 15, 2026 (estimated)
Primary completion
Dec 14, 2029 (estimated)
Completion
Mar 15, 2030 (estimated)
Last update
Sep 23, 2026

Study contacts

Gary Kwok, PhD
Contact
gary.kwok@hmh-cdi.org
2018803057
Gary Kwok, PhD
principal investigator · Hackensack Meridian Health Center for Discovery and Innovation

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion